NCT06994533

Brief Summary

Chest wall tumors are one of the important diseases in thoracic surgery, and surgery is still the main treatment for this disease in clinical practice. Surgery for chest wall tumors requires extensive resection. However, the extensive chest wall defect formed after extensive resection can lead to the destruction of the integrity and stability of the chest wall, thus requiring chest wall reconstruction. The reconstruction of the chest wall after resection has always been a difficult point in chest wall tumor surgery, and the reconstruction of the chest wall bone is a key point in chest wall reconstruction. The goals of successful chest wall bone reconstruction include restoring chest wall rigidity, minimizing chest wall deformities, maintaining lung mechanics, and protecting thoracic organs. At present, traditional reconstruction methods are based on simulating and restoring the anatomical structure of the thoracic spine. For certain special areas of chest wall defects (such as posterior rib and paraspinal tumors), it is difficult to perform residual fixation; At the same time, traditional reconstruction methods suffer from insufficient stability after reconstruction, such as loosening, detachment, displacement, and even fracture. Therefore, it is necessary to design new chest wall reconstruction methods to meet clinical needs.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
33mo left

Started Jul 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jul 2025Dec 2028

First Submitted

Initial submission to the registry

May 11, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 29, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

May 29, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

May 11, 2025

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Stability of implants

    The occurrence of detachment, displacement, and fracture of implants during follow-up in patients undergoing chest wall tumor surgery after receiving a new reconstruction method

    3 years

Secondary Outcomes (10)

  • Respiratory discomfort

    3 years

  • Postoperative complications

    3 years

  • Complications of implants

    3 years

  • Postoperative physical function status

    3 years

  • Quality of life

    3 years

  • +5 more secondary outcomes

Study Arms (2)

new methods on bone reconstruction after chest wall tumor resection

EXPERIMENTAL

Using noose fixation for thoracic bone reconstruction

Procedure: methods on bone reconstrucion after chest wall tumor resection

traditional methods on bone reconstruction after chest wall tumor resection

ACTIVE COMPARATOR

Using bridging method for thoracic bone reconstruction

Procedure: methods on bone reconstrucion after chest wall tumor resection

Interventions

Selecting appropriate implants for chest wall bone reconstruction

new methods on bone reconstruction after chest wall tumor resectiontraditional methods on bone reconstruction after chest wall tumor resection

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old, male or female not limited
  • Anesthesia ASA score I-II
  • Malignant tumor of soft tissue in the chest
  • Malignant tumors of ribs, rib cartilage, and sternum
  • Tumors with uncertain or unknown properties of ribs, rib cartilage, and sternum
  • Giant benign tumors of ribs, rib cartilage, and sternum
  • The preoperative examination results indicate that the tumor has not undergone distant metastasis
  • Willing to participate in the research and sign the informed consent form

You may not qualify if:

  • Patients with distant metastasis detected during preoperative examination
  • Inoperable tumor
  • During the examination, it was discovered that the patient had another type of malignant tumor present
  • ECOG 4
  • Suffering from active or chronic fungal/bacterial/viral infections
  • History of allergy to anesthesia related drugs
  • Heart and lung dysfunction, liver and kidney dysfunction, inability to tolerate surgery
  • Patients with mental disorders who are unable to cooperate with treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Thoracic Surgery

Study Record Dates

First Submitted

May 11, 2025

First Posted

May 29, 2025

Study Start

July 1, 2025

Primary Completion

July 31, 2025

Study Completion (Estimated)

December 31, 2028

Last Updated

May 29, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share